Time-to-conception and clinical pregnancy rate with a myo-inositol, probiotics, and micronutrient supplement: secondary outcomes of the NiPPeR randomized trial.


Journal

Fertility and sterility
ISSN: 1556-5653
Titre abrégé: Fertil Steril
Pays: United States
ID NLM: 0372772

Informations de publication

Date de publication:
06 2023
Historique:
received: 23 05 2022
revised: 11 01 2023
accepted: 30 01 2023
medline: 30 5 2023
pubmed: 9 2 2023
entrez: 8 2 2023
Statut: ppublish

Résumé

To determine whether a combined myo-inositol, probiotics and micronutrient nutritional supplement impacts time-to-natural-conception and clinical pregnancy rates. Secondary outcomes of a double-blind randomized controlled trial. Community recruitment. Women aged 18 to 38 years planning to conceive in the United Kingdom, Singapore, and New Zealand, excluding those with diabetes mellitus or receiving fertility treatment. A standard (control) supplement (folic acid, iron, calcium, iodine, β-carotene), compared with an intervention additionally containing myo-inositol, probiotics, and other micronutrients (vitamins B2, B6, B12, D, zinc). Number of days between randomization and estimated date of natural conception of a clinical pregnancy, as well as cumulative pregnancy rates at 3, 6, and 12 months. Of 1729 women randomized, 1437 (83%; intervention, n=736; control, n=701) provided data. Kaplan-Meier curves of conception were similar between intervention and control groups; the time at which 20% achieved natural conception was 90.5 days (95% confidence interval: 80.7, 103.5) in the intervention group compared with 92.0 days (76.0, 105.1) in the control group. Cox's proportional hazard ratios (HRs) comparing intervention against control for cumulative achievement of pregnancy (adjusted for site, ethnicity, age, body mass index, and gravidity) were similar at 3, 6, and 12 months. Among both study groups combined, overall time-to-conception lengthened with higher preconception body mass index, and was longer in non-White than in White women. Among women who were overweight the intervention shortened time-to-conception compared with control regardless of ethnicity (12-month HR=1.47 [1.07, 2.02], P=.016; 20% conceived by 84.5 vs. 117.0 days) and improved it to that comparable to nonoverweight/nonobese women (20% conceived by 82.1 days). In contrast, among women with obesity, time-to-conception was lengthened with intervention compared with control (12-month HR=0.69 [0.47, 1.00]; P=.053; 20% conceived by 132.7 vs. 108.5 days); an effect predominantly observed in non-White women with obesity. Time-to-natural-conception and clinical pregnancy rates within a year were overall similar in women receiving the intervention supplement compared with control. Overweight women had a longer time-to-conception but there was suggestion that the supplement may shorten their time-to-conception to that comparable to the nonoverweight/nonobese women. Further studies are required to confirm this. clinicaltrials.gov (NCT02509988).

Identifiants

pubmed: 36754158
pii: S0015-0282(23)00128-0
doi: 10.1016/j.fertnstert.2023.01.047
pii:
doi:

Substances chimiques

Inositol 4L6452S749
Micronutrients 0

Banques de données

ClinicalTrials.gov
['NCT02509988']

Types de publication

Randomized Controlled Trial Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1031-1042

Subventions

Organisme : Medical Research Council
ID : MC_UU_12011/4
Pays : United Kingdom
Organisme : Department of Health
ID : NF-SI-0515-10042
Pays : United Kingdom
Organisme : Department of Health
ID : 17/63/154
Pays : United Kingdom
Organisme : Department of Health
ID : IS-BRC-1215-20004
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RG/15/17/3174
Pays : United Kingdom

Investigateurs

Ben Albert (B)
Shirong Cai (S)
Philip C Calder (PC)
Ryan Carvalho (R)
Julie Ann Guiao Castro (JA)
Mary Cavanagh (M)
Jerry Ky Chan (JK)
Mei Ling Chang (ML)
Claudia Chi (C)
Caroline E Childs (CE)
Mei Kit Choh (MK)
Mary Ff Chong (MF)
Anne Hy Chu (AH)
Cathryn Conlon (C)
Cyrus Cooper Paula Costello (CC)
Vanessa Cox (V)
Sevasti Galani (S)
Judith Hammond (J)
Nicholas C Harvey (NC)
Richard Holt (R)
Hazel M Inskip (HM)
Mrunalini Jagtap (M)
Gene Jeon (G)
Neerja Karnani (N)
Chiara Nembrini (C)
Karen A Lillycrop (KA)
Falk Müller-Riemenschneider (F)
Padmapriya Natarajan (P)
Sharon Ng (S)
Adaikalavan Ramasamy (A)
Elizabeth Tham (E)
Mya Thway Tint (MT)
Justin M O'Sullivan (JM)
Gernalia Satianegara (G)
Lynette Pc Shek (LP)
Irma Silva-Zolezzi (I)
Wendy Sim (W)
Shu E Soh (SE)
Vicky Tay (V)
Rachel Taylor (R)
Salika Theodosia (S)
Clare Wall (C)
Gladys Woon (G)
Mark Vickers (M)
Wei Ying (W)

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Shiao-Yng Chan (SY)

Department of Obstetrics and Gynaecology, Yong Loo Lin School of Medicine, National University of Singapore and National University Health System, Singapore; Singapore Institute for Clinical Sciences, Agency for Science, Technology and Research (A∗STAR), Singapore, Singapore. Electronic address: obgchan@nus.edu.sg.

Sheila J Barton (SJ)

Medical Research Council Lifecourse Epidemiology Centre, University of Southampton, Southampton, United Kingdom.

See Ling Loy (SL)

Singapore Institute for Clinical Sciences, Agency for Science, Technology and Research (A∗STAR), Singapore, Singapore; Department of Reproductive Medicine, KK Women's and Children's Hospital, Singapore, Singapore; Duke-NUS Medical School, Singapore, Singapore.

Hsin Fang Chang (HF)

Department of Obstetrics and Gynaecology, Yong Loo Lin School of Medicine, National University of Singapore and National University Health System, Singapore.

Philip Titcombe (P)

Medical Research Council Lifecourse Epidemiology Centre, University of Southampton, Southampton, United Kingdom.

Jui-Tsung Wong (JT)

Singapore Institute for Clinical Sciences, Agency for Science, Technology and Research (A∗STAR), Singapore, Singapore.

Marilou Ebreo (M)

Department of Obstetrics and Gynaecology, Yong Loo Lin School of Medicine, National University of Singapore and National University Health System, Singapore.

Judith Ong (J)

Department of Obstetrics and Gynaecology, Yong Loo Lin School of Medicine, National University of Singapore and National University Health System, Singapore.

Karen Ml Tan (KM)

Singapore Institute for Clinical Sciences, Agency for Science, Technology and Research (A∗STAR), Singapore, Singapore.

Heidi Nield (H)

Medical Research Council Lifecourse Epidemiology Centre, University of Southampton, Southampton, United Kingdom.

Sarah El-Heis (S)

Medical Research Council Lifecourse Epidemiology Centre, University of Southampton, Southampton, United Kingdom.

Timothy Kenealy (T)

Liggins Institute, University of Auckland, Auckland, New Zealand.

Yap-Seng Chong (YS)

Department of Obstetrics and Gynaecology, Yong Loo Lin School of Medicine, National University of Singapore and National University Health System, Singapore; Singapore Institute for Clinical Sciences, Agency for Science, Technology and Research (A∗STAR), Singapore, Singapore.

Philip N Baker (PN)

College of Life Sciences, University of Leicester, Leicester, United Kingdom.

Wayne S Cutfield (WS)

Liggins Institute, University of Auckland, Auckland, New Zealand.

Keith M Godfrey (KM)

Medical Research Council Lifecourse Epidemiology Centre, University of Southampton, Southampton, United Kingdom; National Institute for Health Research Southampton Biomedical Research Centre, University of Southampton, Southampton and University Hospital Southampton National Health Service Foundation Trust, Southampton, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH